Strategic CRO RCRI, Inc. operates as a strategic CRO and consulting partner within the medical device, combination product, IVD, and biologics space. This presents a sales opportunity to offer end-to-end development services, regulatory support, and market readiness solutions to clients seeking integrated concepts-to-revenue pathways.

Covance Affiliation As a Covance by Labcorp company, RCRI benefits from an established corporate backing and credibility in drug development. Leverage Covance’s reputation to position joint offerings, cross-sell across Labcorp’s extensive CRO portfolio, and access a broader client base in life sciences.

Tech Enablement RCRI utilizes a modern tech stack including SAP, IBM SPSS, SAS, MongoDB, Google Cloud Platform, ServiceNow, iCIMS, and SAP. This enables data-driven project management, analytics, and scalable operations—present a value proposition around digital transformation, data analytics, and cloud-based project delivery.

Market Validation Historical recognition and awards in the CRO field, plus strategic asset investments in preclinical oncology facilities, indicate a trajectory of quality and capacity expansion. Position sales pitches around reliability, quality assurance, and expanded capabilities to attract large or safety-critical programs.

Growth & Fit With a lean team size and revenue in the lower mid-market range, there is an opportunity to target mid-sized medical device and diagnostics firms seeking flexible, high-touch CRO services. Propose scalable engagement models, faster time-to-value, and tiered service bundles to match client growth ambitions.